NeurAxis (NASDAQ:NRXS – Get Free Report) and Medtronic (NYSE:MDT – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength ...

The latest trading session saw Medtronic (MDT) ending at $87.72, denoting a -0.45% adjustment from its last day's close. The stock's change was less than the S&P 500's daily gain of 0.38%. Meanwhile, ...

Roots Community Health has sued 12 other firms, including GE Healthcare, CVS and Walgreens, and called for manufacturers and ...

Defensive industries, like healthcare, are more attractive to income investors. That's because companies in this sector are ...

A lawsuit against pulse oximeter manufacturers and distributors is starting to create change. But experts say the FDA needs ...

The three medtech firms unveiled new data this week during TCT 2024 in Washington, D.C. Here’s what the results mean for the ...

Medtronic is modestly undervalued based on DCF analysis, but slow revenue growth limits upside potential. Read why I ...

(Update: Medtronic announced FDA approval for its Affera cardiac mapping and ablation system with the Sphere-9 catheter in October 2024.) Medtronic acquired the Sphere-9 catheter for pulsed field ...

Medtronic USA Inc. and a fired senior director sparred in court Wednesday over the need to physically work in Minnesota to sue under state’s job bias law, with the Eighth Circuit poised to decide ...

Medtronic PLC investors have been content with ... for patients with more than 70 health conditions. The company’s key products include cardiac devices like pacemakers and defibrillators ...

Medtronic (MDT) closed at $91.12 in the latest ... includes the company's expected earnings growth trajectory. Medical - Products stocks are, on average, holding a PEG ratio of 1.94 based on ...